Company / Operating Margin
BioMarin Pharmaceutical Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
12.7%
FY2025
5-year range
-4.5% / 17.0%
FY2021-FY2025
Trend
-25.1%
vs FY2024
Sector context
#36 of 136
Health Care
What the data says
At 12.7%, BioMarin Pharmaceutical's operating margin ranks #36 of 136 in the Health Care sector. Operating Margin has fluctuated over the past 10 years, ranging from -71.9% in FY2016 to 17.0% in FY2024.
Based on SEC 10-K filings.
12.7% in FY2025 with a 5-year CAGR of +15.0%.
Improved from 7.7% to 12.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +5.0pp
- 5-Year Change
- +15.0pp
- 10-Year Change
- -
Sector benchmark
#36 of 136 in Health CareTop 26% of 136This company 12.7% Sector average -778.9%
▼
+101.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 25.1% year-over-year.
- Currently 791.6pp above the Health Care sector average.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.7% | -25.1% |
| FY2024 | 17.0% | +121.0% |
| FY2023 | 7.7% | +0.0% |
| FY2022 | 7.7% | +272.2% |
| FY2021 | -4.5% | -91.4% |
| FY2020 | -2.3% | +60.5% |
| FY2019 | -5.9% | +28.7% |
| FY2018 | -8.3% | -639.3% |
| FY2017 | -1.1% | +98.4% |
| FY2016 | -71.9% | -478.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026